Cargando…

Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model

Background: Recently, we demonstrated the beneficial effects of engineered heart tissues for the treatment of dilated cardiomyopathy in rats. For further development of this technique we started to produce engineered tissue (ET) from mesenchymal stem cells. Interestingly, we observed a malignant tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Spath, Cathleen, Schlegel, Franziska, Leontyev, Sergey, Mohr, Friedrich-Wilhelm, Dhein, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627979/
https://www.ncbi.nlm.nih.gov/pubmed/23616767
http://dx.doi.org/10.3389/fphar.2013.00042
_version_ 1782266366057775104
author Spath, Cathleen
Schlegel, Franziska
Leontyev, Sergey
Mohr, Friedrich-Wilhelm
Dhein, Stefan
author_facet Spath, Cathleen
Schlegel, Franziska
Leontyev, Sergey
Mohr, Friedrich-Wilhelm
Dhein, Stefan
author_sort Spath, Cathleen
collection PubMed
description Background: Recently, we demonstrated the beneficial effects of engineered heart tissues for the treatment of dilated cardiomyopathy in rats. For further development of this technique we started to produce engineered tissue (ET) from mesenchymal stem cells. Interestingly, we observed a malignant tumor invading the heart with an inverse relationship between proliferation markers and connexin expression. Methods: Commercial CD54(+)/CD90(+)/CD34(−)/CD45(−) bone marrow derived mesenchymal rat stem cells (cBM-MSC), characterized were used for production of mesenchymal stem-cell-ET (MSC-ET) by suspending them in a collagen I, matrigel-mixture and cultivating for 14 days with electrical stimulation. Three MSC-ET were implanted around the beating heart of adult rats for days. Another three MSC-ET were produced from freshly isolated rat bone marrow derived stem cells (sBM-MSC). Results: Three weeks after implantation of the MSC-ETs the hearts were surgically excised. While in 5/6 cases the ET was clearly distinguishable and was found as a ring containing mostly connective tissue around the heart, in 1/6 the heart was completely surrounded by a huge, undifferentiated, pleomorphic tumor originating from the cMSC-ET (cBM-MSC), classified as a high grade malignant sarcoma. Quantitatively we found a clear inverse relationship between cardiac connexin expression (Cx43, Cx40, or Cx45) and increased Ki-67 expression (Cx43: p < 0.0001, Cx45: p < 0.03, Cx40: p < 0.014). At the tumor-heart border there were significantly more Ki-67 positive cells (p = 0.001), and only 2% Cx45 and Ki-67-expressing cells, while the other connexins were nearly completely absent (p < 0.0001). Conclusion and Hypothesis: These observations strongly suggest the hypothesis, that invasive tumor growth is accompanied by reduction in connexins. This implicates that gap junction communication between tumor and normal tissue is reduced or absent, which could mean that growth and differentiation signals can not be exchanged.
format Online
Article
Text
id pubmed-3627979
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-36279792013-04-24 Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model Spath, Cathleen Schlegel, Franziska Leontyev, Sergey Mohr, Friedrich-Wilhelm Dhein, Stefan Front Pharmacol Pharmacology Background: Recently, we demonstrated the beneficial effects of engineered heart tissues for the treatment of dilated cardiomyopathy in rats. For further development of this technique we started to produce engineered tissue (ET) from mesenchymal stem cells. Interestingly, we observed a malignant tumor invading the heart with an inverse relationship between proliferation markers and connexin expression. Methods: Commercial CD54(+)/CD90(+)/CD34(−)/CD45(−) bone marrow derived mesenchymal rat stem cells (cBM-MSC), characterized were used for production of mesenchymal stem-cell-ET (MSC-ET) by suspending them in a collagen I, matrigel-mixture and cultivating for 14 days with electrical stimulation. Three MSC-ET were implanted around the beating heart of adult rats for days. Another three MSC-ET were produced from freshly isolated rat bone marrow derived stem cells (sBM-MSC). Results: Three weeks after implantation of the MSC-ETs the hearts were surgically excised. While in 5/6 cases the ET was clearly distinguishable and was found as a ring containing mostly connective tissue around the heart, in 1/6 the heart was completely surrounded by a huge, undifferentiated, pleomorphic tumor originating from the cMSC-ET (cBM-MSC), classified as a high grade malignant sarcoma. Quantitatively we found a clear inverse relationship between cardiac connexin expression (Cx43, Cx40, or Cx45) and increased Ki-67 expression (Cx43: p < 0.0001, Cx45: p < 0.03, Cx40: p < 0.014). At the tumor-heart border there were significantly more Ki-67 positive cells (p = 0.001), and only 2% Cx45 and Ki-67-expressing cells, while the other connexins were nearly completely absent (p < 0.0001). Conclusion and Hypothesis: These observations strongly suggest the hypothesis, that invasive tumor growth is accompanied by reduction in connexins. This implicates that gap junction communication between tumor and normal tissue is reduced or absent, which could mean that growth and differentiation signals can not be exchanged. Frontiers Media S.A. 2013-04-17 /pmc/articles/PMC3627979/ /pubmed/23616767 http://dx.doi.org/10.3389/fphar.2013.00042 Text en Copyright © 2013 Spath, Schlegel, Leontyev, Mohr and Dhein. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Pharmacology
Spath, Cathleen
Schlegel, Franziska
Leontyev, Sergey
Mohr, Friedrich-Wilhelm
Dhein, Stefan
Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model
title Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model
title_full Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model
title_fullStr Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model
title_full_unstemmed Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model
title_short Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model
title_sort inverse relationship between tumor proliferation markers and connexin expression in a malignant cardiac tumor originating from mesenchymal stem cell engineered tissue in a rat in vivo model
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627979/
https://www.ncbi.nlm.nih.gov/pubmed/23616767
http://dx.doi.org/10.3389/fphar.2013.00042
work_keys_str_mv AT spathcathleen inverserelationshipbetweentumorproliferationmarkersandconnexinexpressioninamalignantcardiactumororiginatingfrommesenchymalstemcellengineeredtissueinaratinvivomodel
AT schlegelfranziska inverserelationshipbetweentumorproliferationmarkersandconnexinexpressioninamalignantcardiactumororiginatingfrommesenchymalstemcellengineeredtissueinaratinvivomodel
AT leontyevsergey inverserelationshipbetweentumorproliferationmarkersandconnexinexpressioninamalignantcardiactumororiginatingfrommesenchymalstemcellengineeredtissueinaratinvivomodel
AT mohrfriedrichwilhelm inverserelationshipbetweentumorproliferationmarkersandconnexinexpressioninamalignantcardiactumororiginatingfrommesenchymalstemcellengineeredtissueinaratinvivomodel
AT dheinstefan inverserelationshipbetweentumorproliferationmarkersandconnexinexpressioninamalignantcardiactumororiginatingfrommesenchymalstemcellengineeredtissueinaratinvivomodel